Kura Oncology, Inc. KURA
- darlifarnib — Renal Cell Carcinoma Phase 1
- darlifarnib — Non-Small Cell Lung Cancer Phase 1
- darlifarnib — Colorectal Cancer Phase 1
- darlifarnib — Pancreatic Ductal Adenocarcinoma Phase 1
Home › Targets › farnesyl transferase
Companies with an active program directed at farnesyl transferase.